سعر موفيزي 5 مجم 20 قرص مغلف 2023

Moveasy 5 mg film-coated tablets (Global Napi): cyclobenzaprine skeletal muscle relaxant, 20 tablets.

• Adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions (short-term use up to 2–3 weeks).DailyMed / FDA

• Most common: drowsiness, dry mouth, dizziness, fatigue, headache. Postmarketing: serotonin syndrome, arrhythmias, hypersensitivity including anaphylaxis.International label, same formulation · DailyMed / FDA

• Hypersensitivity; concomitant MAO inhibitors or within 14 days of discontinuation; acute recovery phase of MI; arrhythmias, heart block, conduction disturbances, or CHF; hyperthyroidism.International label, same formulation · DailyMed / FDA

• Serotonin syndrome risk with SSRIs/SNRIs/TCAs/tramadol/MAOIs and related agents; may impair alertness; enhances CNS depressants/alcohol; anticholinergic caution (glaucoma, urinary retention).International label, same formulation · DailyMed / FDA
• Not effective for spasticity due to CNS disease or cerebral palsy; pediatric safety/effectiveness below 15 years not established.International label, same formulation · DailyMed / FDA

• MAO inhibitorsMajorContraindicated: hyperpyretic crisis, seizures and deaths reported with concomitant or recent MAOI use.DailyMed / FDA
• SSRIs, SNRIs, TCAs, tramadol, bupropion, meperidine, verapamilMajorSerotonin syndrome risk; discontinue both agents if syndrome suspected; careful observation if coadministration warranted.DailyMed / FDA
• Alcohol, barbiturates, other CNS depressantsModerateCyclobenzaprine may enhance CNS depressant effects.DailyMed / FDA

• Animal studies showed no evidence of fetal harm at up to ~20× human dose; no adequate well-controlled studies in pregnant women. Use during pregnancy only if clearly needed.International label, same formulation · DailyMed / FDA
• Unknown whether excreted in human milk; related tricyclic antidepressants appear in milk — exercise caution in nursing women.International label, same formulation · DailyMed / FDA

• Cyclobenzaprine: Acts primarily within the CNS at the brain stem; reduces tonic somatic motor activity influencing both alpha and gamma motor systems.